Login / Signup

High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis.

Andrea VianelloGiovanna ArcaroBeatrice MolenaCristian TuratoFausto BraccioniLuciana PaladiniStefania VioSilvia FerraresePiera PedittoFederico GallanMarina Saetta
Published in: Therapeutic advances in respiratory disease (2019)
Short-term mortality fell to below 50% when a treatment algorithm incorporating HFNC was implemented in a group of patients with AE-IPF admitted to a RICU for ARF. Patients not responding to conventional oxygen therapy seemed to benefit from HFNC. The reviews of this paper are available via the supplementary material section.
Keyphrases